Marksans Pharma gains on recalling one batch of Metformin Extended Release Tablets

08 Jun 2020 Evaluate

Marksans Pharma is currently trading at Rs. 32.45, up by 0.65 points or 2.04% from its previous closing of Rs. 31.80 on the BSE.

The scrip opened at Rs. 33.35 and has touched a high and low of Rs. 33.35 and Rs. 30.25 respectively. So far 2357417 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 33.35 on 08-Jun-2020 and a 52 week low of Rs. 9.90 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 33.35 and Rs. 23.00 respectively. The current market cap of the company is Rs. 1344.60 crore.

The promoters holding in the company stood at 48.25%, while Institutions and Non-Institutions held 3.43% and 48.32% respectively.

Marksans Pharma has issued voluntary recall of one batch of Metformin Extended Release Tablets USP 500 mg (11279 bottles, Lot No. XP9004) due to detection of NDMA as a matter of abundant precaution.

Metformin Extended Release Tablets USP 500 mg is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus.

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×